Disclosures Alphabetical List

  • Cheri Abbott has no relevant financial relationships to disclose.
  • Steven Abman has served as a Consultant, Advisory Board Member or Steering Committee Member for Shire Pharmaceuticals. Abman has received other grant or research support from Actelion Pharmaceuticals Ltd and Shire Pharmaceuticals.
  • Mary Alderman has no relevant financial relationships to disclose.
  • William Auger has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Healthcare Pharmaceuticals LLC. Auger has received Institutional Grant or Research Support from Bayer Healthcare Pharmaceuticals LLC and US CTEPH Registry.
  • Eric Austin has received Institutional Grant or Research Support from NIH.
  • Lauren Axelrod has served as a Consultant, Advisory Board Member or Steering Committee Member for Arena Pharmaceuticals, Inc and Actelion Pharmaceuticals Ltd. Axelrod has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd.
  • Matthew Bacchetta has no relevant financial relationships to disclose.
  • Mary Bartlett has no relevant financial relationships to disclose.
  • Christopher Barnett has no relevant financial relationships to disclose.
  • David Badesch has served as a Consultant, Advisory Board Member or Steering Committee Member for Acceleron Pharma Inc. Badesch has a financial relationship with Actelion Pharmaceuticals Ltd, Arena Pharmaceuticals Inc and Liquidia Technologies. Badesch has received Institutional Grant or Research Support from Acceleron Pharma, Inc, Actelion Pharmaceuticals Ltd, Arena Pharmaceuticals Inc, Eiger Biopharmaceuticals, Inc, Complexa, Liquidia and United Therapeutics. Badesch has received other grant or research support from NIH, USPHSR (The United States Pulmonary Hypertension Scientific Registry). Badesch is a self-managed Stock Shareholder for Johnson & Johnson.
  • Aaron Bagnola has no relevant financial relationships to disclose.
  • Vijay Balasubramanian has no relevant financial relationships to disclose.
  • Mary Bartlett has no relevant financial relationships to disclose.
  • Sonja Bartolome has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Healthcare Pharmaceuticals LLC and Actelion Pharmaceuticals Ltd. Bartolome has received Institutional Grant or Research Support from Reata Pharmaceuticals, Inc, United Therapeutics Corporation, Arena Pharmaceuticals, Inc, Pfizer, Inc and PhaseBio.
  • Angela Bautista has no relevant financial relationships to disclose.
  • Erika Berman Rosenzweig has no relevant financial relationships to disclose.
  • April Blakley has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation.
  • Lynn Brown has no relevant financial relationships to disclose.
  • Brett Brunetti has no relevant financial relationships to disclose.
  • Colleen Brunetti has no relevant financial relationships to disclose.
  • Todd Bull has served as a Consultant, Advisory Board Member or Steering Committee Member for Liquidia Technologies. Bull has received other grant or research support from Bayer Healthcare Pharmaceuticals LLC and through a Bayer-Investigator Initiated Grant.
  • Frank Cann has no relevant financial relationships to disclose.
  • Hugo Carmona has no relevant financial relationships to disclose.
  • Marcia Cerise has no relevant financial relationships to disclose.
  • Murali Chakinala has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Medscape, Express Scripts Holding Company, Reata Pharmaceuticals, Inc, PhaseBio, Arena and Akros. Chakinala has served on a Speaker’s Bureau for Gilead Sciences, Inc Ltd and Bayer Healthcare Pharmaceuticals LLC. Chakinala has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, Medtronic, Reata Pharmaceuticals, Inc, NIH, Eiger, Liquidia, PhaseBio, Arena and Complexa.
  • Edward Chen has no relevant financial relationships to disclose.
  • Kelly Chin has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Johnson & Johnson, Bayer Healthcare Pharmaceuticals LLC and Arena Pharmaceuticals, Inc. Chin has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC and Ironwood. Chin has a personal financial relationship with the American Heart Association (AHA) as Circulation Associate Editor.
  • Amy Chybowski has no relevant financial relationships to disclose.
  • Lorinda Chug has served as a Consultant, Advisory Board Member or Steering Committee Member for Reata, Third Rock Ventures, Incyte, Mitsubishi Tanabe, Global Blood Therapeutics, Bristol-Myers Squibb, Eicos and Boehringer Ingelheim.
  • Colleen Connor has no relevant financial relationships to disclose.
  • Gerilynn Connors has no relevant financial relationships to disclose.
  • Nicole Creech has received Institutional Grant or Research Support from Janssen Pharmaceutical NV. She sat on a panel of peers (i.e. other PH patients) to discuss thoughts and opinions about what other “medical” services, or how those “medical” services could be offered to the PH Community (i.e. Palliative Care), and what that might look like, when offered (i.e. At what point would those services be most beneficial to a patient? At diagnosis, or at a later date; and how would that information be presented, in a binder or communicated via medical personnel?). Honorarium received totaled $343.83.
  • Ankit Desai has no relevant financial relationships to disclose.
  • Ramona Doyle has served as a Consultant, Advisory Board Member or Steering Committee Member for Complexa Inc.
  • Hilary DuBrock has no relevant financial relationships to disclose.
  • Daniel Dumitrescu has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd and Novertis Pharmaceuticals. Dumitrescu has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, GlaxoSmithKline and Merck & Co., Inc and has received speaker fees from Servier. Badesch has received grant or research support from Actelion Pharmaceuticals Ltd.
  • Laura Duvall has no relevant financial relationships to disclose.
  • Jean Elwing has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics, Bayer Corporation and Actelion Pharmaceutical Us, Inc. Elwing has received Institutional Grant or Research Support from Actelion Pharmaceuticals US, Inc, Arena, Reata, United Therapeutics, Bellevue Pharmacy Solutions, Bellerophon, Lung Biotechnology, Eiger, PhaseBio, Complexa, Liquidia and Akros.
  • Karen Fagan has no relevant financial relationships to disclose.
  • Harrison Farber has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, United Therapeutics Corporation, Arena Pharmaceuticals Inc and Bristol Myers Squibb. Farber has served as a Speaker’s Bureau for Actelion Pharmaceuticals Ltd and Bayer Healthcare Pharmaceuticals LLC.
  • Mary Jo Farmer has no relevant financial relationships to disclose.
  • Adrian Felder has no relevant financial relationships to disclose.
  • Benjamin Freed has no relevant financial relationships to disclose.
  • Jeffrey Fineman has no relevant financial relationships to disclose.
  • Jen Fox has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Healthcare Pharmaceuticals LLC.
  • Kathryn Frix has no relevant financial relationships to disclose.
  • Stacey Gausling has no relevant financial relationships to disclose.
  • Mardi Gomberg-Maitland has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Janssen Pharmaceuticals NV, Acceleron Pharma, Inc, Merck & Co., Inc., Complexa, Gassamier, United Therapeutics and Reata.
  • Carla Hall has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation.
  • Lillian Hansen has served as a Consultant, Advisory Board Member, or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC and United Therapeutics Corporation. Hansen has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC and United Therapeutics Corporation.
  • Anna Hemnes has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, United Therapeutics Corporation and Complexa. Hemnes has received Institutional Grant or Research Support from NIH and CMREF (The Cardiovascular Medical Research and Education Fund). Hemnes has received other grant or research support from NIH and CMREF.
  • Gustavo Heresi has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Corporation and Arena. Heresi has served on a Speaker’s Bureau for Bayer Corporation.
  • Susan Hoelle has no relevant financial relationships to disclose.
  • William Hoff has no relevant financial relationships to disclose.
  • Rachel Hopper has no relevant financial relationships to disclose.
  • Dunbar Ivy has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, Eli Lilly and Company, GlaxoSmithKline and United Therapeutics. Ivy has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, Eli Lilly and Company and United Therapeutics Corporation. Ivy has received other grant or research support from United Therapeutics Corporation and Gilead Sciences, Inc.
  • Kimberly Jackson has served on a Speaker’s Bureau for United Therapeutics and Actelion Pharmaceuticals Ltd.
  • William Jansen has no relevant financial relationships to disclose.
  • Loida Johnson has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Healthcare Pharmaceuticals LLC.
  • Martin Johnson has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd. Johnson has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd and Merck & Co. Inc.
  • Edward Kirkpatrick has no relevant financial relationships to disclose.
  • Seth Kligerman has no relevant financial relationships to disclose.
  • Amy Kimber has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion, Bayer and Arena.
  • Jessie Kohler has no relevant financial relationships to disclose.
  • Mitchell Koppelman has no relevant financial relationships to disclose.
  • Richard Krasuski has served as a Consultant, Advisory Board Member or Steering Committee Member from Actelion Pharmaceuticals Ltd and Ventripoint Diagnostics. Krasuski has received other grant or research support from Actelion Pharmaceuticals Ltd and Edwards Life Sciences. Krasuski has a personal financial relationship for travel funding from Medtronic.
  • Usha Krishnan has no relevant financial relationships to disclose.
  • Richard Kronmal has no relevant financial relationships to disclose.
  • Tim Lahm has no relevant financial relationships to disclose.
  • Matthew Lammi has no relevant financial relationships to disclose.
  • Tony Lahnston has no relevant financial relationships to disclose.
  • Deborah Jo Levine has no relevant financial relationships to disclose.
  • Roberto Machado has served as a Consultant, Advisory Board Member or Steering Committee Member for Complexa Indriol CXA-10-301. Machado has received Institutional Grant or Research Support from AADi. Machado has received other grant or research support from NHLBI.
  • S. Melissa Magness has no relevant financial relationships to disclose.
  • Stephen Mathai has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, United Therapeutics Corporation and Arena Pharmaceuticals, Inc. Mathai has served on a Speaker’s Bureau for PHA. Mathai has received other grant or research support NIH/NHLBI.
  • Susie McDevitt has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation, Bayer Healthcare Pharmaceuticals LLC and Liquidia Technologies.
  • Michael McGoon has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation, Pfizer, Inc and Acceleron Pharma, Inc.
  • Vallerie Mclaughlin has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Us, Inc, Bayer Corporation, United Therapeutics, Arena, Acceleron Pharma, Caremark, Corsair and CiVi Biopharma, Inc. Mclaughlin has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd, Bayer Corporation, Canadian Heart Research, Reata, NIH, Acceleron Pharma, Inc, SoniVie Ltd, United Therapeutics and Eiger Biopharmaceuticals, Inc.
  • Lana Melendres-Groves has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Ltd and United Therapeutics Corporation. Melendres-Groves has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd, Bayer HealthCare Pharmaceuticals LLC and United Therapeutics Corporation.
  • Sarah Miranda has no relevant financial relationships to disclose.
  • Barbara Monaghan has no relevant financial relationships to disclose.
  • Nick Morrell has no relevant financial relationships to disclose.
  • Kathleen Morris has no relevant financial relationships to disclose.
  • Mary Mullen has received Institutional Grant or Research Support from NIH/NHLBI (National Heart, Lung, and Blood Institute).
  • Steven Nathan has served as a Consultant, Advisory Board Member, or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC, F. Hoffman-La Roche Ltd, Lung Biotechnology PBC, Bellerophon and Third Pole. Nathan has served on a Speaker’s Bureau for Bayer Healthcare Pharmaceuticals LLC and United Therapeutics Corporation. Nathan has received Institutional Grant or Research Support from United Therapeutics Corporation, Lung Biotechnology PBC and Bellerophon Therapeutics
  • Clarissa Nemeth has no relevant financial relationships to disclose.
  • Ellen Newton-Lovato has no relevant financial relationships to disclose.
  • Ron Oudiz has served as Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Gilead Sciences. Inc, United Therapeutics Corporation, Reata Pharmaceuticals, Inc, Complexa and Arena. Oudiz has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd, Gilead Sciences, Inc, and United Therapeutics Corporation. Oudiz has received Institutional Grant or Research Support from Actelion Pharmaceuticals Ltd, United Therapeutics Corporation, Liquidia Technologies, GlaxoSmithKline, AADi, Reata and Arena.
  • Monica Penaranda has no relevant financial relationships to disclose.
  • Janet Pinson has no relevant financial relationships to disclose.
  • Sudhakar Pipavath has served as a Consultant, Advisory Board Member or Steering Committee Member for Boehringer Ingelheim.
  • Abigail Poms has no relevant financial relationships to disclose.
  • Diane Ramirez has no relevant financial relationships to disclose.
  • Gautam Ramani has no relevant financial relationships to disclose.
  • Nicole Reid has no relevant financial relationships to disclose.
  • Jonathan Rich has no relevant financial relationships to disclose.
  • Franz Rischard has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation. Rischard has received Institutional Grant or Research Support from Acceleron Pharma, Inc, Actelion Pharmaceuticals Ltd, Arena Pharmaceuticals, Inc, Bayer Healthcare Pharmaceuticals LLC, AADi, Complexa, United Therapeutics and the National Heart and Lung and Blood Division (NHLBI) of the NIH.
  • Erik Rodriquez has no relevant financial relationships to disclose.
  • Erika Rosenzweig has received Institutional Grant or Research Support from Actelion Pharmaceuticals Us, Inc, Gilead Sciences, Bayer Corporation, Glaxo Smithkline and United Therapeutics.
  • Fran Rogers has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation and Actelion Pharmaceuticals Ltd.
  • Mitchell Roppalman has a former employer stock investment plan with Pfizer stock fund.
  • James Runo has served on a Speaker’s Bureau for Simply Speaking.
  • Jeffrey Sage has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceutical LLC, Gilead Sciences, Inc and United Therapeutics. Sager has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd, United Therapeutics Corporation, Bayer Healthcare Pharmaceuticals LLC, Gilead sciences, Inc and Insmed. Sager has received Institutional Grant or Research Support from Lung Biotechnology PBC, United Therapeutics Corporation, Actelion Pharmaceuticals Ltd, Arena Pharmaceuticals, Inc and Reata. Sager has received other grant or research support from Cottage Health Research Institute.
  • Ann Schmit has no relevant financial relationships to disclose.
  • Oksana Shlobin has served as a Consultant, Advisory Board Member or Steering Committee Member for Bayer Healthcare Pharmaceuticals LLC, Johnson & Johnson, and United Therapeutics Corporation. Shlobin has served on a Speaker’s Bureau for Bayer Healthcare Pharmaceuticals LLC, Johnson & Johnson and United Therapeutics Corporation.
  • Marc Simon has served as a Consultant, Advisory Board Member or Steering Committee Member for Complexa, United Therapeutics and Actelion Pharmaceuticals Us, Inc.
  • Kerri Smith has received Institutional Grant or Research Support from United Therapeutics, Actelion Pharmaceuticals Us, Inc, Reata and Bayer Corporation.
  • Sean Studer has served on a Speaker’s Bureau for Actelion Pharmaceuticals Us, Inc., Bayer Corporation, Genentech, Gilead Sciences and United Therapeutics.
  • Traci Stewart has no relevant financial relationships to disclose.
  • Yon Sung has no relevant financial relationships to disclose.
  • John Swisher has no relevant financial relationships to disclose.
  • Arunabh Talwar has no relevant financial relationships to disclose.
  • Douglas Taylor has no relevant financial relationships to disclose. Taylor is a self-managed stock shareholder with United Therapeutics.
  • Thenappan Thenappan has received Institutional Grant or Research Support from United Therapeutics Corporation, Liquidia Technologies and Tenax Corporation.
  • Roger Towle has no relevant financial relationships to disclose.
  • Glenna Traiger has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd and United Therapeutics Corporation. Traiger has served on a Speaker’s Bureau for Actelion Pharmaceuticals Ltd.
  • Anjali Vaidya has served as a Consultant, Advisory Board Member or Steering Committee Member for Actelion Pharmaceuticals Ltd, Bayer Healthcare Pharmaceuticals LLC and United Therapeutics Corporation. Vaidya has served on a Speaker’s Bureau for Bayer Healthcare Pharmaceuticals LLC, Actelion Pharmaceuticals Ltd, United Therapeutics Corporation and Gilead Sciences, Inc.
  • Nidhy Varghese has no relevant financial relationships to disclose.
  • Natasha Vedage has no relevant financial relationships to disclose.
  • Corey Ventetuolo has served as a Consultant, Advisory Board Member or Steering Committee Member for Acceleron Pharma, Inc. Ventetuolo has received Institutional Grant or Research Support from Eiger Biopharmaceuticals, Inc and United Therapeutics Corporation. Ventetuolo’s spouse is employed by CVS Health.
  • Patricia Wasserman has no relevant financial relationships to disclose.
  • Aaron Waxman has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation and Acceleron Pharma, Inc. Waxman has a personal financial relationship as a self-managed stock shareholder with Gossamer Pharm.
  • Matt Wall has no relevant financial relationships to disclose.
  • Kayleen Williams has no relevant financial relationships to disclose.
  • Tim Williamson has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation. Willamson has received Institutional Grant or Research Support from United Therapeutics Corporation, Actelion Pharmaceuticals Ltd, Liquidia Technologies and Bayer Healthcare Pharmaceuticals LLC.
  • Melisa Wilson has served as a Consultant, Advisory Board Member or Steering Committee Member for United Therapeutics Corporation. Wilson has served on a Speaker’s Bureau for United Therapeutics Corporation, Bayer Healthcare Pharmaceuticals LLC and Actelion Pharmaceuticals Ltd.
  • James Wilson has no relevant financial relationships to disclose.
  • Mark Wittenstein has no relevant financial relationships to disclose.
  • Kimberly Winters has no relevant financial relationships to disclose.
  • Wei Wu has no relevant financial relationships to disclose.
  • Delphine Yung has no relevant financial relationships to disclose.
  • Allyson Zazulia has served as a Consultant, Advisory Board Member or Steering Committee Member for Minnitronix. Zazulia has served on a board of directors for Mid-America Transplant Services.

Last Updated: Nov., 2019